Gynecologic and Obstetric Investigation

Case Report

A Case of Adenomyosis per se with a Uterine Weight of 475 g

Harmanli O.H.a · Shen T.b · Zhu S.b · Chatwani A.J.a

Author affiliations

Departments of aObstetrics and Gynecology and bPathology, Temple University School of Medicine, Philadelphia,Pa., USA

Related Articles for ""

Gynecol Obstet Invest 2004;58:216–218

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Received: May 10, 2004
Accepted: July 08, 2004
Published online: November 17, 2004
Issue release date: November 2004

Number of Print Pages: 3
Number of Figures: 4
Number of Tables: 0

ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)

For additional information: https://www.karger.com/GOI

Abstract

Background: Adenomyosis alone usually does not cause significant uterine enlargement. Case: A 49-year-old woman underwent vaginal hysterectomy and pelvic reconstructive surgery for pelvic organ prolapse. Incidentally, she was found to have adenomyosis with a 475-gram uterus without any other uterine histopathologic finding. To our knowledge, this is the largest uterus with adenomyosis alone ever reported. Conclusion: Extreme enlargement of the uterus is possible due to adenomyosis alone.

© 2004 S. Karger AG, Basel




Related Articles:


References

  1. Molitor JJ: Adenomyosis: A clinical and pathological appraisal. Am J Obstet Gynecol 1971;10:275–282.
    External Resources
  2. Matalliotakis IM, Kourtis AI, Panidis DK: Adenomyosis. Obstet Gynecol Clin North Am 2003;30:63–82.
  3. LevGur M, Abadi MA, Tucker A: Adenomyosis: Symptoms, histology, and pregnancy terminations. Obstet Gynecol 2000;95:688–691.
  4. LevGur M: The enlarged uterus: Relation of the uterine size to symptoms and histopathologic findings. J Reprod Med 1996;41:166–170.
  5. Cullen TS (ed): Adenomyoma of the Uterus. Philadelphia, Saunders Co, 1908.
  6. Reiter RC, Wagner PL, Gambone JC: Routine hysterectomy for large aymptomatic uterine fibroids: A reappraisal. Obstet Gynecol 1992;79:481–484.
  7. Dueholm M, Lundorf E, Hansen ES, Sorensen JS, Ledertoug S, Olesen F: Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril 2001;76:588–594.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Received: May 10, 2004
Accepted: July 08, 2004
Published online: November 17, 2004
Issue release date: November 2004

Number of Print Pages: 3
Number of Figures: 4
Number of Tables: 0

ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)

For additional information: https://www.karger.com/GOI


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP